ARTICLES BY LAURIE HALLORAN

• The 6 Pillars Of Effectively Managing Up In Clinical Development

  7/22/2021

  Managing up, regardless of title, can be a challenging skill to master from the onset. Laurie Halloran and Michelle Pratt of Halloran Consulting share their 6 key lessons that they've learned along their careers in clinical development. This article will help you manage your relationships with your colleagues in a more senior role, while also positioning yourself for success.

• Starting A Career In Clinical Research: 7 Things We Wish We Knew

  11/24/2020

  The clinical research industry is facing a talent shortage that could become acute in the next decade. A main contributor to this shortage is a lack of focused intervention at every level to identify the skills, behaviors, and knowledge that will enable motivated candidates to begin and mature their careers in the industry. 

• Discovering & Motivating Talent In The Life Sciences: Redefining “Other Duties & Responsibilities”

  8/21/2020

  How do we attract the right kind of talent to a role within our organizations? How do we take the same innovative approaches in our talent acquisition processes that we put into our products? One answer can be found in an often-overlooked bullet point in a common job description: “other duties and responsibilities as required.”

• Clinical Study Risk Management During The COVID-19 Pandemic

  4/6/2020

  While COVID-19 has proven to be an extremely trying obstacle for the life science community, it is crucial for organizations to not only focus on the short-term impacts of COVID-19 but on developing a long-term plan of action for how we return to business once the pandemic subsides.

• Clinical Study Conduct During The COVID-19 Pandemic — Challenges & Solutions

  4/6/2020

  Life science companies across the world are scrambling to mitigate the impacts of COVID-19 on their clinical studies and business operations, and there are no clear-cut answers at this time, nor a one-size-fits-all solution. But what we do know is that we are all in this together and that this is another challenge that the biotech industry was built for.

• Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits

  3/19/2020

   

  While we have not seen any significant delays in regulatory approval of life science products to date, the impact of COVID-19 on regulatory interactions, inspections, audits, and global health authorities is continuing to evolve.

   

• Can New York City Lead In Life Sciences?

  9/7/2017

  New York City has long aspired to become a life sciences hub, but while the city seems to have all the elements necessary to foster such industry growth, it has continually fallen short of this goal.